These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 19025433)

  • 21. Phosphodiesterase inhibitors in refractory heart failure: bridge to beta-blockade?
    De Marco T; Chatterjee K
    J Am Coll Cardiol; 1998 May; 31(6):1341-3. PubMed ID: 9581730
    [No Abstract]   [Full Text] [Related]  

  • 22. [Is it always necessary to use triple combination in the treatment of patients with chronic cardiac failure? Choice of the third neurohormonal blocker].
    Belenkov IuN; Mareev VIu; Skvortsov AA
    Ter Arkh; 2008; 80(9):5-12. PubMed ID: 19555028
    [No Abstract]   [Full Text] [Related]  

  • 23. Neurohormonal inhibition in heart failure: insights from recent clinical trials.
    Gheorghiade M; De Luca L; Bonow RO
    Am J Cardiol; 2005 Dec; 96(12A):3L-9L. PubMed ID: 16399087
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Beta-adrenergic blockers in heart failure: review of mechanisms of action and clinical outcomes.
    Satwani S; Dec GW; Narula J
    J Cardiovasc Pharmacol Ther; 2004 Dec; 9(4):243-55. PubMed ID: 15678243
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Heart failure with normal left ventricular ejection fraction: what is the evidence?
    Kindermann M; Reil JC; Pieske B; van Veldhuisen DJ; Böhm M
    Trends Cardiovasc Med; 2008 Nov; 18(8):280-92. PubMed ID: 19345315
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanisms of neurohormonal activation in chronic congestive heart failure: pathophysiology and therapeutic implications.
    Dávila DF; Núñez TJ; Odreman R; de Dávila CA
    Int J Cardiol; 2005 Jun; 101(3):343-6. PubMed ID: 15907399
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Resting heart rate does not reflect the degree of beta-blockade in subjects with heart failure on chronic beta-blocker therapy.
    Mignatti A; Sims DB; Colombo PC; Garcia LI; Bijou R; Deng MC; Jorde UP
    Cardiovasc Ther; 2009; 27(1):42-8. PubMed ID: 19207479
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular restoration of beta-adrenergic receptor signaling improves contractile function of failing hearts.
    Tevaearai HT; Koch WJ
    Trends Cardiovasc Med; 2004 Aug; 14(6):252-6. PubMed ID: 15451518
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heart rate decrease: a new paradigm in the treatment of heart failure. Insights from the SHIFT study.
    Komajda M
    Arch Cardiovasc Dis; 2011 Feb; 104(2):67-9. PubMed ID: 21402339
    [No Abstract]   [Full Text] [Related]  

  • 30. Impact of adenosine receptor signaling and metabolism on pathophysiology in patients with chronic heart failure.
    Asakura M; Asanuma H; Kim J; Liao Y; Nakamaru K; Fujita M; Komamura K; Isomura T; Furukawa H; Tomoike H; Kitakaze M
    Hypertens Res; 2007 Sep; 30(9):781-7. PubMed ID: 18037770
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of refractory heart failure.
    Dei Cas L; Metra M; Nodari S; Raddino R; Bonandi L; Visioli O
    Cardiologia; 1992 Jul; 37(7):501-5. PubMed ID: 8521428
    [No Abstract]   [Full Text] [Related]  

  • 32. Low-level inotropic stimulation with type III phosphodiesterase inhibitors in patients with advanced symptomatic chronic heart failure receiving beta-blocking agents.
    Shakar SF; Bristow MR
    Curr Cardiol Rep; 2001 May; 3(3):224-31. PubMed ID: 11305977
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Phosphodiesterase inhibitors].
    Sarkis A; Pornin M
    Ann Cardiol Angeiol (Paris); 1990 Sep; 39(7):427-31. PubMed ID: 2264708
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nebivolol: a third-generation beta-blocker for hypertension.
    Cheng JW
    Clin Ther; 2009 Mar; 31(3):447-62. PubMed ID: 19393838
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Utility of beta-blockers in the treatment of chronic heart failure].
    Raymondi DM; Velasco A; Cordero A; Mejía S; Alegría E
    Rev Med Univ Navarra; 2003; 47(2):18-22. PubMed ID: 14635412
    [TBL] [Abstract][Full Text] [Related]  

  • 36. About "Resting heart rate does not reflect the degree of beta-blockade in subjects with heart failure on chronic beta-blocker therapy".
    Carvalho VO
    Cardiovasc Ther; 2009; 27(3):221. PubMed ID: 19689621
    [No Abstract]   [Full Text] [Related]  

  • 37. Beta-blockers for preventing sudden cardiac death.
    Giles TD; Basile JN
    Postgrad Med; 2003 Dec; 114(6 Suppl Role):30-4. PubMed ID: 19667667
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Future aspects of new cardiotonic drugs].
    Hori M; Sato H; Kamata T
    Nihon Naika Gakkai Zasshi; 1994 Jan; 83(1):59-63. PubMed ID: 9132455
    [No Abstract]   [Full Text] [Related]  

  • 39. [Possibilities and problems of using beta-adrenoblockers in chronic heart failure].
    Lopatin IuM; Gkhani P; Mareev VIu; Belenkov IuN
    Ter Arkh; 1993; 65(9):85-8. PubMed ID: 7905673
    [No Abstract]   [Full Text] [Related]  

  • 40. Heart failure, atrial fibrillation, and beta-blockers.
    van Veldhuisen DJ; Crijns HJ; van den Berg MP
    Eur Heart J; 2006 Jan; 27(2):247. PubMed ID: 16311238
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.